Home  >  Products  >  MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)) Blocking Peptide (the N terminal of protein) (100ug)
MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)) Blocking Peptide (the N terminal of protein) (100ug)

MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MLH1 antibody (Catalogue #: ARP56076_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP56076
Size: 100 ug
Weight: 84kDa
Gene: 4292
Format: Lyophilized powder
Target: This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). It is a human homolog of the E. coli DNA mismatch repair gene mutL, consistent with the characteristic alterations in microsatellite sequences (RER+phenotype) found in HNPCC.This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). It is a human homolog of the E. coli DNA mismatch repair gene mutL, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Alternatively spliced transcript variants encoding different isoforms have been described, but their full-length natures have not been determined. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: COCA2; FCC2; HNPCC; HNPCC2; MGC5172; hMLH1
See Full Product Listings >